BioPharma Company Screener
Filter 954 biotech and pharmaceutical companies. Data sourced from SEC EDGAR (SIC codes 2833-2836, 8731).
954 Companies
| Ticker | Company | Sector | Exchange | SIC | Grade | Pipeline |
|---|---|---|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| INCY | INCYTE CORP | Biotech R&D | Nasdaq | 8731 | A+ | 4 drugs |
| INDP | Indaptus Therapeutics, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| INDV | Indivior Pharmaceuticals, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | A+ | 4 drugs |
| IFRX | InflaRx N.V. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| IKT | Inhibikase Therapeutics, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| INTI | Inhibitor Therapeutics, Inc. | Pharmaceutical Preparations | OTC | 2834 | D | 0 drugs |
| INBX | Inhibrx Biosciences, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| INM | InMed Pharmaceuticals Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| INMB | Inmune Bio, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| IPHYF | Innate Pharma SA | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| IPHA | Innate Pharma SA | Diagnostics | Nasdaq | 2836 | A | 1 drugs |
| INNP | INNOCAN PHARMA Corp | Pharmaceutical Preparations | 2834 | D | 0 drugs | |
| INNPF | INNOCAN PHARMA Corp | Pharmaceutical Preparations | 2834 | — | 0 drugs | |
| INVA | Innoviva, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| NOTV | Inotiv, Inc. | Biotech R&D | Nasdaq | 8731 | D | 0 drugs |
| INO | INOVIO PHARMACEUTICALS, INC. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| IMDX | Insight Molecular Diagnostics Inc. | Diagnostics | Nasdaq | 2835 | D | 0 drugs |
| INSM | INSMED Inc | Pharmaceutical Preparations | Nasdaq | 2834 | A+ | 2 drugs |
| TIL | Instil Bio, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| INBP | INTEGRATED BIOPHARMA INC | Pharmaceutical Preparations | OTC | 2834 | D | 0 drugs |
| NTLA | Intellia Therapeutics, Inc. | Diagnostics | Nasdaq | 2835 | D | 0 drugs |
| INTS | INTENSITY THERAPEUTICS, INC. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| INCR | Intercure Ltd. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| ISCO | International Stem Cell CORP | Pharmaceutical Preparations | OTC | 2834 | D | 0 drugs |
| IVEVF | Inventiva S.A. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| IVA | Inventiva S.A. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| IVVD | Invivyd, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| IOBTQ | IO Biotech, Inc. | Pharmaceutical Preparations | OTC | 2834 | D | 0 drugs |
| IONS | IONIS PHARMACEUTICALS INC | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| IQV | IQVIA HOLDINGS INC. | Biotech R&D | NYSE | 8731 | D | 0 drugs |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| ISPC | iSpecimen Inc. | Biotech R&D | Nasdaq | 8731 | D | 0 drugs |
| ITRMF | Iterum Therapeutics plc | Pharmaceutical Preparations | Nasdaq | 2834 | — | 0 drugs |
| JBIO | Jade Biosciences, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| JAGX | Jaguar Health, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| JANX | Janux Therapeutics, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| JSPRW | Jasper Therapeutics, Inc. | Diagnostics | Nasdaq | 2836 | — | 0 drugs |
| JSPR | Jasper Therapeutics, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |
| JAZZ | Jazz Pharmaceuticals plc | Pharmaceutical Preparations | Nasdaq | 2834 | A+ | 4 drugs |
| JNJ | JOHNSON & JOHNSON | Pharmaceutical Preparations | NYSE | 2834 | D | 0 drugs |
| DERM | Journey Medical Corp | Pharmaceutical Preparations | Nasdaq | 2834 | A+ | 4 drugs |
| JUNS | JUPITER NEUROSCIENCES, INC. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| JUSHF | Jushi Holdings Inc. | Pharmaceutical Chemicals | OTC | 2833 | D | 0 drugs |
| MENS | Jyong Biotech Ltd. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| KLRA | Kailera Therapeutics, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| KAPA | Kairos Pharma, LTD. | Pharmaceutical Preparations | NYSE | 2834 | D | 0 drugs |
| KALA | KALA BIO, Inc. | Pharmaceutical Preparations | Nasdaq | 2834 | D | 0 drugs |
| KLRS | Kalaris Therapeutics, Inc. | Diagnostics | Nasdaq | 2836 | D | 0 drugs |